4DMT and ROCHE Expand Ophthalmology Partnership to Develop … – Business Wire (press release)
Business Wire (press release) |
4DMT and ROCHE Expand Ophthalmology Partnership to Develop …
Business Wire (press release) 4D Molecular Therapeutics (4DMT), a leader in Therapeutic Vector Evolution for adeno-associated virus (AAV) gene therapy vector discovery and product. Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy … |
